Human Microbiome Market By Product (Obesity, Diabetes, Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, and Other Diseases), By Disease (Probiotics, Prebiotics, Synbiotic, and Other Products), By Application (Therapeutic and Diagnostic), and By Region- Trends, Analysis and Forecast till 2030

Report Code: PMI378719 | Publish Date: May 2024 | No. of Pages: 180

Global Human Microbiome Market By Overview

Human Microbiome Market accounted for USD 590.39 Million in 2020 and is estimated to be USD 3657.31 Million by 2030 and is anticipated to register a CAGR of 19.8%. 

Human microbiome are present inside the surface of human body, for example skin, intestine, mouth covered with individual microbes. These human microbes are not harmful for human health. These essential microorganisms helps to perform the functions of body properly. The human microbiome helps us to keep infected harmful microbes away, these microorganisms are also called as the normal body flora. The organs with the human microbes are considered as the sterile organs.     

Global Human Microbiome Market By Drivers & Restraints

Growing prevalence of chronic diseases

Changing lifestyle and growing prevalence of chronic diseases, mainly cardiovascular diseases, cancer, type 2 diabetes mellitus, and respiratory diseases are the major driving factor for the growth of global market. As per the data of WHO (World’s Health Organization), globally in 2016, cardiovascular diseases (CVD) are the main cause of death, around 17.9 million people died due to CVDs, which represented 31% of all deaths, globally. Most of these deaths were due to cardiac arrests and strokes, and were observed mostly in the low- and middle-income countries. Additionally, the increasing geriatric population is the propelling factor for the growth of target market. Moreover, the human microbes are used to diagnosis the boosting factor for the growth of target market. However, lack of comprehensive in the research and development of the human microbes is the major restraining factor for the growth human microbiome market. In addition, the strict rules and regulation on the experiments on human is the hampering factor for the growth of target market.

Global Human Microbiome Market By Segmentations & Regional Insights

The human microbiome market is segmented based on product, disease, application, and region.

On the basis of product, the human microbiome market is segmented into obesity, diabetes, autoimmune disorder, cancer, gastrointestinal disorders, central nervous system disorders, and other diseases. On the basis of disease, the target market is segmented into probiotics, prebiotics, synbiotic, and other products. Based on application, the global market is classified into therapeutic and diagnostic.

Regional Insights:

Based on region, the human microbiome market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of disease. In North America region the increasing awareness about human microbes is driving growth of the global market in this region. Moreover, investments into research and development for the better healthcare is anticipated to create growth opportunities for the Asia Pacific human microbiome market.

Human Microbiome Market, By Product:

  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Other Diseases

Human Microbiome Market, By Disease:

  • Probiotics
  • Prebiotics
  • Synbiotic
  • Other Products

Human Microbiome Market, By Application:

  • Therapeutic
  • Diagnostic

Human Microbiome Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Human Microbiome Market, By Product
      • Middle East & Africa Human Microbiome Market, By Disease
      • Middle East & Africa Human Microbiome Market, By Application
      • Middle East & Africa Human Microbiome Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Human Microbiome Market, By Product
      • Latin America Human Microbiome Market, By Disease
      • Latin America Human Microbiome Market, By Application
      • Latin America Human Microbiome Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Human Microbiome Market, By Product
      • Asia Pacific Human Microbiome Market, By Disease
      • Asia Pacific Human Microbiome Market, By Application
      • Asia Pacific Human Microbiome Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific                                                                                                                                                                                           
    • Europe
      • Europe Human Microbiome Market, By Product
      • Europe Human Microbiome Market, By Disease
      • Europe Human Microbiome Market, By Application
      • Europe Human Microbiome Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Human Microbiome Market, By Product
    • North America Human Microbiome Market, By Disease
    • North America Human Microbiome Market, By Application
    • North America Human Microbiome Market, By Country
      • U.S.
      • Canada

Global Human Microbiome Market By Competitive Landscape & Key Players

The key players operating the human microbiome market involves Enterome Bioscience, Yakult, Dow DuPont Inc., Seres Therapeutics, ViThera Pharmaceuticals, Second Genome Inc., MatriSys Bioscience, Caelus Health, Rebiotix Inc., Assembly Biosciences Inc. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

Global Human Microbiome Market By Company Profile

  • Enterome Bioscience
  • Yakult
  • Dow DuPont Inc.
  • Seres Therapeutics
  • ViThera Pharmaceuticals
  • Second Genome Inc.
  • MatriSys Bioscience
  • Caelus Health
  • Rebiotix Inc.
  • Assembly Biosciences Inc.

FAQs

The Global Human Microbiome Market is valued at US$510.12 million in 2020.

The Global Human Microbiome Market is projected to increase at a CAGR of 18.2% during the forecast period.

The global human microbiome market is segmented based on product, disease, application, and region.

Changing lifestyle and growing prevalence of chronic diseases, mainly cardiovascular diseases, cancer, type 2 diabetes mellitus, and respiratory diseases are the major driving factor for the growth of global market.

Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.